Biopharmaceutical firm AbbVie, Inc. (NYSE: ABBV) introduced first-quarter 2025 monetary outcomes, reporting an increase in revenue and adjusted earnings. The…
Browsing: AbbVie
Try the corporations making headlines in noon buying and selling: Apple — Shares rebounded more than 5% on Wednesday after…
AbbVie Announces European Commission Approval of RINVOQ ® (upadacitinib) for the Treatment of Adults with Giant Cell Arteritis Source link…
Firm Announcement AbbVie Inc. information criticism in opposition to Genmab within the U.S. District Courtroom for the Western District of…